MyMD Pharmaceuticals Inc (MYMD)

[knuts4oe]

MyMD Pharma's 2nd path to success
On July 27, 2021 MyMD Pharma released the results of a study conducted by Eurofins Discovery that compared the results of MYMD-1, acting as a JAK inhibitor against 3 popular JAK inhibitors, and found the results to be similar. That means that MYMD-1 could garner its share of this market when it becomes a drug, a market of about 20 million a year, forcasted to grow to 300 million a year by 2026, a growth rate exceeding 50 % a year.
https://www.businesswire.com/news/home/20210727005570/en/MyMD-Pharmaceuticals%E2%80%99-Lead-Compound-MYMD-1-Shows-Commonality-in-Comparative-Study-with-FDA-Approved-Anti-Inflammatory-and-Anti-Autoimmune-Drugs-Used-for-Arthritis-Colitis-and-Dermatitis